LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

Search

Hologic Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

64.32 2.11

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

62.96

Max

64.57

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-218M

-17M

Pardavimai

-17M

1B

P/E

Sektoriaus vid.

26.055

51.198

Pelnas, tenkantis vienai akcijai

1.03

Pelno marža

-1.731

Darbuotojai

7,063

EBITDA

-359M

-7M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+5.36% upside

Dividendai

By Dow Jones

Kitas uždarbis

2025-07-28

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-1.1B

14B

Ankstesnė atidarymo kaina

62.21

Ankstesnė uždarymo kaina

64.32

Naujienos nuotaikos

By Acuity

24%

76%

56 / 380 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Bullish Evidence

Hologic Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-05-27 18:46; UTC

Pagrindinės rinkos jėgos
Įsigijimai, susijungimai, perėmimai

Hologic Shares Up Following Report of Buyout Offer From TPG, Blackstone

2025-05-27 20:07; UTC

Įsigijimai, susijungimai, perėmimai

Hologic Stock Is Surging. Why Shares of the MedTech Company Are Up 14%. -- Barrons.com

2025-05-27 19:06; UTC

Įsigijimai, susijungimai, perėmimai

Hologic Stock Is Surging. Why Shares of the MedTech Company Are Up 14%. -- Barrons.com

2025-05-27 18:26; UTC

Įsigijimai, susijungimai, perėmimai

Hologic Stock Is Surging. Why Shares of the MedTech Company Are Up 19%. -- Barrons.com

Akcijų palyginimas

Kainos pokytis

Hologic Inc Prognozė

Kainos tikslas

By TipRanks

5.36% į viršų

12 mėnesių prognozė

Vidutinis 66.45 USD  5.36%

Aukščiausias 71 USD

Žemiausias 60 USD

Remiantis 14 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Hologic Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

14 ratings

5

Pirkti

9

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

52.69 / 58.605Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Bullish Evidence

Vidutinės trukmės periodas

Weak Bearish Evidence

Ilgalaikis periodas

Bearish Evidence

Rinkos nuotaikos

By Acuity

56 / 380 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Labai stiprus bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Aukščiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Hologic Inc

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, and specimen radiology solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, it offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. The company was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.